Mobia Medical (NASDAQ:MOBI) Announces Quarterly Earnings Results, Misses Expectations By $0.06 EPS

Mobia Medical (NASDAQ:MOBI) posted its quarterly earnings data on Thursday. The company reported ($0.52) EPS for the quarter, missing the consensus estimate of ($0.46) by ($0.06), FiscalAI reports. The company had revenue of $15.62 million for the quarter. The business’s quarterly revenue was up 73.3% compared to the same quarter last year.

Here are the key takeaways from Mobia Medical’s conference call:

• Third-quarter revenue rose 73% year over year to $15.6 million, ahead of expectations, prompting Mobia to raise its 2026 revenue outlook to $57.0 million–$57.5 million from $54 million–$56 million.
• Growth was driven disproportionately by adoption at existing programs, while average active territories increased 78% year over year to 40. Management said it plans to keep adding territories at a measured, consistent pace.
• Mobia pointed to the inclusion of paired vagus nerve stimulation in updated AHA/ASA stroke recovery guidelines and favorable reimbursement infrastructure, including a Category 1 CPT code and an average Medicare payment of about $45,000, as factors supporting adoption. Management said the recent OPPS rule supports its reimbursement strategy.
• Operating expenses increased to $31.5 million from $18.4 million, largely reflecting commercial hiring and higher stock-based compensation, and the quarterly net loss widened to $17.3 million from $11.4 million. The company reported $160.7 million in cash and said it expects gross margin to remain in the low 80% range.

Mobia Medical Price Performance

Mobia Medical stock traded down $0.35 during midday trading on Friday, reaching $10.93. 100,991 shares of the company traded hands, compared to its average volume of 177,467. The company has a debt-to-equity ratio of 0.04, a current ratio of 13.28 and a quick ratio of 12.80. Mobia Medical has a 12 month low of $8.03 and a 12 month high of $15.29. The stock has a market cap of $363.86 million and a price-to-earnings ratio of -0.54. The company’s 50 day simple moving average is $9.99.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on MOBI. BTIG Research reiterated a “buy” rating and set a $20.00 target price on shares of Mobia Medical in a report on Friday. Weiss Ratings started coverage on Mobia Medical in a research note on Wednesday, August 12th. They issued a “sell (e-)” rating on the stock. Finally, JPMorgan Chase & Co. raised their price objective on Mobia Medical from $15.00 to $17.00 and gave the company an “overweight” rating in a research report on Wednesday, August 12th. Five equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $21.00.

Insider Activity at Mobia Medical

In other news, Director Casey Tansey bought 16,441 shares of the stock in a transaction on Tuesday, August 18th. The shares were bought at an average price of $12.07 per share, with a total value of $198,442.87. Following the completion of the acquisition, the director owned 318,332 shares in the company, valued at $3,842,267.24. The trade was a 5.45% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders acquired a total of 87,000 shares of company stock valued at $1,016,367 over the last three months.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the business. Readystate Asset Management LP bought a new position in Mobia Medical in the 2nd quarter worth $134,000. Citadel Advisors LLC bought a new position in shares of Mobia Medical in the second quarter worth about $670,000. State Street Corp bought a new position in shares of Mobia Medical in the second quarter worth about $735,000. Finally, University of Texas Texas AM Investment Management Co. bought a new position in shares of Mobia Medical in the third quarter worth about $1,019,000.

Mobia Medical Company Profile

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc is based in AUSTIN, Texas.